HAMAD MEDICAL CORPORATION

🇶🇦Qatar

Country: 🇶🇦Qatar

Ownership: -

Established: 1979-01-01

Employees: -

Market Cap: -

Website: https://www.hamad.qa

Clinical Trials

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Phase 3

Conditions: PreDiabetes
Myocardial Infarction
T2DM (Type 2 Diabetes Mellitus)
CVD

Interventions: Drug: Dapagliflozin 10mg

First Posted Date: 2018-09-05

Last Posted Date: 2019-01-03

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 576

Registration Number: NCT03658031

Locations: 🇶🇦
Heart Hospital, Hamad Medical Coorporation, Doha, Qatar

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping

Phase 3

Conditions: Blood Transfusion, Homologous
Blood Disease
Blood Transfusion, Autologous
Blood Doping

Interventions: Biological: Homologous Blood Transfusion
Biological: Autologous Blood Transfusion

First Posted Date: 2018-06-07

Last Posted Date: 2020-08-11

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 12

Registration Number: NCT03548766

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

Phase 1

Recruiting

Conditions: Anaphylaxis

Interventions: Drug: Dexamethasone Oral

First Posted Date: 2018-05-14

Last Posted Date: 2024-08-14

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 210

Registration Number: NCT03523221

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Clinical Trial Comparing Intravenous and Oral Diclofenac and Pharmacokinetics

Phase 4

Conditions: Pain Management
Limb Injury

Interventions: Drug: Diclofenac Sodium

First Posted Date: 2018-03-21

Last Posted Date: 2018-03-22

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 300

Registration Number: NCT03472339

Locations: 🇶🇦
Isma Qureshi, Doha, Qatar

Oxidative Stress In Semen And Male Infertility

Phase 4

Conditions: Semen Quality
Antioxidants
Infertility, Male

Interventions: Drug: Fairhaven Pro for men
Diagnostic Test: Semen analysis
Diagnostic Test: Sperm DNA fragmentation
Diagnostic Test: Static Oxidation reduction potential in semen

First Posted Date: 2018-03-14

Last Posted Date: 2018-03-14

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 100

Registration Number: NCT03464656

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

A Biorepository for Coronary Heart Disease in Qatar

Completed

Conditions: Coronary Heart Disease (CHD)

First Posted Date: 2018-02-09

Last Posted Date: 2018-08-01

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 2100

Registration Number: NCT03427489

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Qatar Cardiometabolic Registry

Recruiting

Conditions: Diabetes Mellitus
Cardiovascular Diseases

First Posted Date: 2018-01-09

Last Posted Date: 2018-01-09

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 50000

Registration Number: NCT03394313

Locations: 🇶🇦
Hamad Medical Coorporation, Doha, Qatar

Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock

Phase 2

Terminated

Conditions: Septic Shock
Critical Illness

Interventions: Drug: Triple therapy group

First Posted Date: 2017-12-21

Last Posted Date: 2021-12-10

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 106

Registration Number: NCT03380507

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

The Recurrence Study

Not Applicable

Conditions: Acute Stroke
Transient Ischemic Attack

Interventions: Diagnostic Test: Corneal Confocal Imaging
Diagnostic Test: Magnetic resonance Imaging
Other: Blood sample

First Posted Date: 2017-08-09

Last Posted Date: 2017-08-09

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 300

Registration Number: NCT03244215

Locations: 🇶🇦
The Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar

An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes

Phase 3

Conditions: Diabetic Nephropathies

Interventions: Drug: Calcitriol

First Posted Date: 2017-07-13

Last Posted Date: 2018-09-06

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 320

Registration Number: NCT03216564

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy